Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering

Bibliographic Details
Main Author: Yazdanpanah, Ayna
Publication Date: 2022
Other Authors: Madjd, Zahra, Pezeshki-Modaress, Mohamad, Khosrowpour, Zahra, Farshi, Paniz, Eini, Leila, Kiani, Jafar, Seifi, Morteza, Kundu, Subhas C, Ghods, Roya, Gholipourmale, Mazaher
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://hdl.handle.net/1822/90021
Summary: Background Synthetic tissue engineering scaffolds has poor biocompatiblity with very low angiogenic properties. Conditioning the scaffolds with functional groups, coating with biological components, especially extracellular matrix (ECM), is an excellent strategy for improving their biomechanical and biological properties. Methods In the current study, a composite of polycaprolactone and gelatin (PCL/Gel) was electrospun in the ratio of 70/30 and surface modified with 1% gelatin-coating (G-PCL/Gel) or plasma treatment (P-PCL/Gel). The surface modification was determined by SEM and ATR-FTIR spectroscopy, respectively. The scaffolds were cultured with fibroblast 3T3, then decellularized during freeze-thawing process to fabricate a fibroblast ECM-conditioned PCL/Gel scaffold (FC-PCL/Gel). The swelling and degaradtion as well as in vitro and in vivo biocompatibility and angiogenic properties of the scaffolds were evaluated. Results The structure of the surface-modified G-PCL/Gel and P-PCL/Gel were unique and not changed compared with the PCL/Gel scaffolds. ATR-FTIR analysis admitted the formation of oxygen-containing groups, hydroxyl and carboxyl, on the surface of the P-PCL/Gel scaffold. The SEM micrographs and DAPI staining confirmed the cell attachment and the ECM deposition on the platform and successful removal of the cells after decellularization. P-PCL/Gel showed better cell attachment, ECM secretion and deposition after decellularization compared with G-PCL/Gel. The FC-PCL/Gel was considered as an optimized scaffold for further assays in this study. The FC-PCL/Gel showed increased hydrophilic behavior and cytobiocompatibility compared with P-PCL/Gel. The ECM on the FC-PCL/Gel scaffold showed a gradual degradation during 30 days of degradation time, as a small amount of ECM remained over the FC-PCL/Gel scaffold at day 30. The FC-PCL/Gel showed significant biocompatibility and improved angiogenic property compared with P-PCL/Gel when subcutaneously implanted in a mouse animal model for 7 and 28 days. Conclusions Our findings suggest FC-PCL/Gel as an excellent biomimetic construct with high angiogenic properties. This bioengineered construct can serve as a possible application in our future pre-clinical and clinical studies for skin regeneration.
id RCAP_82ecd138b9ed2a132a8f4fd4145ef8c8
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/90021
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering3T3 fibroblastCell adhesionCell attachmentElectrospunExtracellular matrixPlasma treatmentPolycaprolactoneScience & TechnologyBackground Synthetic tissue engineering scaffolds has poor biocompatiblity with very low angiogenic properties. Conditioning the scaffolds with functional groups, coating with biological components, especially extracellular matrix (ECM), is an excellent strategy for improving their biomechanical and biological properties. Methods In the current study, a composite of polycaprolactone and gelatin (PCL/Gel) was electrospun in the ratio of 70/30 and surface modified with 1% gelatin-coating (G-PCL/Gel) or plasma treatment (P-PCL/Gel). The surface modification was determined by SEM and ATR-FTIR spectroscopy, respectively. The scaffolds were cultured with fibroblast 3T3, then decellularized during freeze-thawing process to fabricate a fibroblast ECM-conditioned PCL/Gel scaffold (FC-PCL/Gel). The swelling and degaradtion as well as in vitro and in vivo biocompatibility and angiogenic properties of the scaffolds were evaluated. Results The structure of the surface-modified G-PCL/Gel and P-PCL/Gel were unique and not changed compared with the PCL/Gel scaffolds. ATR-FTIR analysis admitted the formation of oxygen-containing groups, hydroxyl and carboxyl, on the surface of the P-PCL/Gel scaffold. The SEM micrographs and DAPI staining confirmed the cell attachment and the ECM deposition on the platform and successful removal of the cells after decellularization. P-PCL/Gel showed better cell attachment, ECM secretion and deposition after decellularization compared with G-PCL/Gel. The FC-PCL/Gel was considered as an optimized scaffold for further assays in this study. The FC-PCL/Gel showed increased hydrophilic behavior and cytobiocompatibility compared with P-PCL/Gel. The ECM on the FC-PCL/Gel scaffold showed a gradual degradation during 30 days of degradation time, as a small amount of ECM remained over the FC-PCL/Gel scaffold at day 30. The FC-PCL/Gel showed significant biocompatibility and improved angiogenic property compared with P-PCL/Gel when subcutaneously implanted in a mouse animal model for 7 and 28 days. Conclusions Our findings suggest FC-PCL/Gel as an excellent biomimetic construct with high angiogenic properties. This bioengineered construct can serve as a possible application in our future pre-clinical and clinical studies for skin regeneration.We express our sincere thanks to Dr Mohammad Amin Haramshahi, Dr Sara Simorgh, and Miss Roya Sajed for helpful comments on this work. This study is extracted from the thesis written by Ayna Yazdanpanah and funded by a grant from the Iran University of Medical Sciences under grant number y(33225) and the animal study ethical committee confirmation code of IR.IUMS. REC.1397.469. SCK is European Research Area Chair in the FoReCaST project (European Commission—H2020- WIDESPREAD-2014-668983) and FCT—Portuguese project BREAST-IT (PTDC/BTM-ORG/28168/2017) supported SCK.WileyUniversidade do MinhoYazdanpanah, AynaMadjd, ZahraPezeshki-Modaress, MohamadKhosrowpour, ZahraFarshi, PanizEini, LeilaKiani, JafarSeifi, MortezaKundu, Subhas CGhods, RoyaGholipourmale, Mazaher2022-012022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/90021engYazdanpanah A., Madjd Z., Pezeshki-Modaress M., Khosrowpour Z., Farshi P., Eini L., Kiani J., Seifi M., Kundu S. C., Ghods R., Gholipourmale M. Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering, Artificial Organs, 2022, Vol. 46, Issue 6, pp. 1040-1054, doi:https://doi.org/10.1111/aor.14169.0160-564X1525-159410.1111/aor.1416935006608https://onlinelibrary.wiley.com/doi/10.1111/aor.14169info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-11T07:34:03Zoai:repositorium.sdum.uminho.pt:1822/90021Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T16:31:38.891445Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
title Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
spellingShingle Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
Yazdanpanah, Ayna
3T3 fibroblast
Cell adhesion
Cell attachment
Electrospun
Extracellular matrix
Plasma treatment
Polycaprolactone
Science & Technology
title_short Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
title_full Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
title_fullStr Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
title_full_unstemmed Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
title_sort Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering
author Yazdanpanah, Ayna
author_facet Yazdanpanah, Ayna
Madjd, Zahra
Pezeshki-Modaress, Mohamad
Khosrowpour, Zahra
Farshi, Paniz
Eini, Leila
Kiani, Jafar
Seifi, Morteza
Kundu, Subhas C
Ghods, Roya
Gholipourmale, Mazaher
author_role author
author2 Madjd, Zahra
Pezeshki-Modaress, Mohamad
Khosrowpour, Zahra
Farshi, Paniz
Eini, Leila
Kiani, Jafar
Seifi, Morteza
Kundu, Subhas C
Ghods, Roya
Gholipourmale, Mazaher
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Yazdanpanah, Ayna
Madjd, Zahra
Pezeshki-Modaress, Mohamad
Khosrowpour, Zahra
Farshi, Paniz
Eini, Leila
Kiani, Jafar
Seifi, Morteza
Kundu, Subhas C
Ghods, Roya
Gholipourmale, Mazaher
dc.subject.por.fl_str_mv 3T3 fibroblast
Cell adhesion
Cell attachment
Electrospun
Extracellular matrix
Plasma treatment
Polycaprolactone
Science & Technology
topic 3T3 fibroblast
Cell adhesion
Cell attachment
Electrospun
Extracellular matrix
Plasma treatment
Polycaprolactone
Science & Technology
description Background Synthetic tissue engineering scaffolds has poor biocompatiblity with very low angiogenic properties. Conditioning the scaffolds with functional groups, coating with biological components, especially extracellular matrix (ECM), is an excellent strategy for improving their biomechanical and biological properties. Methods In the current study, a composite of polycaprolactone and gelatin (PCL/Gel) was electrospun in the ratio of 70/30 and surface modified with 1% gelatin-coating (G-PCL/Gel) or plasma treatment (P-PCL/Gel). The surface modification was determined by SEM and ATR-FTIR spectroscopy, respectively. The scaffolds were cultured with fibroblast 3T3, then decellularized during freeze-thawing process to fabricate a fibroblast ECM-conditioned PCL/Gel scaffold (FC-PCL/Gel). The swelling and degaradtion as well as in vitro and in vivo biocompatibility and angiogenic properties of the scaffolds were evaluated. Results The structure of the surface-modified G-PCL/Gel and P-PCL/Gel were unique and not changed compared with the PCL/Gel scaffolds. ATR-FTIR analysis admitted the formation of oxygen-containing groups, hydroxyl and carboxyl, on the surface of the P-PCL/Gel scaffold. The SEM micrographs and DAPI staining confirmed the cell attachment and the ECM deposition on the platform and successful removal of the cells after decellularization. P-PCL/Gel showed better cell attachment, ECM secretion and deposition after decellularization compared with G-PCL/Gel. The FC-PCL/Gel was considered as an optimized scaffold for further assays in this study. The FC-PCL/Gel showed increased hydrophilic behavior and cytobiocompatibility compared with P-PCL/Gel. The ECM on the FC-PCL/Gel scaffold showed a gradual degradation during 30 days of degradation time, as a small amount of ECM remained over the FC-PCL/Gel scaffold at day 30. The FC-PCL/Gel showed significant biocompatibility and improved angiogenic property compared with P-PCL/Gel when subcutaneously implanted in a mouse animal model for 7 and 28 days. Conclusions Our findings suggest FC-PCL/Gel as an excellent biomimetic construct with high angiogenic properties. This bioengineered construct can serve as a possible application in our future pre-clinical and clinical studies for skin regeneration.
publishDate 2022
dc.date.none.fl_str_mv 2022-01
2022-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1822/90021
url https://hdl.handle.net/1822/90021
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Yazdanpanah A., Madjd Z., Pezeshki-Modaress M., Khosrowpour Z., Farshi P., Eini L., Kiani J., Seifi M., Kundu S. C., Ghods R., Gholipourmale M. Bioengineering of fibroblast-conditioned polycaprolactone/gelatin electrospun scaffold for skin tissue engineering, Artificial Organs, 2022, Vol. 46, Issue 6, pp. 1040-1054, doi:https://doi.org/10.1111/aor.14169.
0160-564X
1525-1594
10.1111/aor.14169
35006608
https://onlinelibrary.wiley.com/doi/10.1111/aor.14169
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596001407991808